Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
New report reveals rare cancers are more prevalent than ever, leading experts to call for an overhaul in how they are defined and treated
Today, Australia’s leading cancer experts, politicians, and people with lived experience of cancer are meeting…
Dramatic rise in UK liver cancer cases linked to poverty
Liver Cancer UK, part of the British Liver Trust, has released new findings today which…
Prostate cancer screening: Men who spent adequate time with their doctors are more likely to have productive discussions
Members of the University of Ottawa Department of Family Medicine, Canada, conducted a scoping review…
Zika virus’ key into brain cells ID’d, leveraged to block infection and kill cancer cells
Zika virus infection can stunt neonatal brain development, a condition known as microcephaly, in which babies are born with abnormally…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.